Duarte, California
Phase 1 cancer trials in Duarte, CA
109 Phase 1 cancer studies are recruiting participants at sites in Duarte as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Duarte at a glance
- 109 studies are recruiting at a site in Duarte.
- By phase: Early Phase 1 (2), Phase 1 (75), Phase 1/2 (32).
- By sponsor: industry (71), university, hospital or other (32), government (6).
- By research area: Lymphoma (53), Breast Cancer (22), Lung Cancer (20), Prostate Cancer (7), Pancreatic Cancer (5), Melanoma (2).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Duarte
Basic details from each study's public record (the 30 most recently updated of 109). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- City of Hope
- Registry record
- NCT07020117 · updated
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- City of Hope
- Registry record
- NCT06638307 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- City of Hope Comprehensive Cancer Center
- Registry record
- NCT07503808 · updated
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- City of Hope - Duarte
- Registry record
- NCT03424005 · updated
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- ORIC Pharmaceuticals
- Study site
- City of Hope
- Registry record
- NCT05315700 · updated
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- City of Hope
- Registry record
- NCT07029399 · updated
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
- Registry record
- NCT07318805 · updated
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- City of Hope National Medical Center
- Registry record
- NCT06465069 · updated
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- City of Hope
- Registry record
- NCT07114601 · updated
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- Phase 1/2
- Ages 18 and older
- Female participants
- Sponsor
- Hoffmann-La Roche
- Study site
- City of Hope
- Registry record
- NCT04802759 · updated
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT06130826 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Duarte, CA on ClinicalTrials.gov.
Lung cancer studies recruiting in Duarte
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- City of Hope Comprehensive Cancer Center
- Registry record
- NCT06287775 · updated
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- City of Hope Cancer Center-Duarte
- Registry record
- NCT07277413 · updated
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- City of Hope-Duarte-56419
- Registry record
- NCT04886804 · updated
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- City of Hope National Medical Center
- Registry record
- NCT07090499 · updated
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Pierre Fabre Medicament
- Study site
- City of Hope
- Registry record
- NCT06043817 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Duarte, CA on ClinicalTrials.gov.
Prostate cancer studies recruiting in Duarte
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Duarte Cancer Center
- Registry record
- NCT05997615 · updated
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Amgen
- Study site
- City of Hope National Medical Center
- Registry record
- NCT04221542 · updated
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT05805371 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Duarte, CA on ClinicalTrials.gov.
Lymphoma studies recruiting in Duarte
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT07109219 · updated
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT07758673 · updated
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- City of Hope Comprehensive Cancer Center
- Registry record
- NCT05272384 · updated
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- PeproMene Bio, Inc.
- Study site
- City of Hope Medical Center
- Registry record
- NCT05370430 · updated
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT07278856 · updated
Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT06922604 · updated
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- City of Hope
- Registry record
- NCT07101328 · updated
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- City of Hope
- Registry record
- NCT07226843 · updated
Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT05371132 · updated
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
- Phase 1
- Ages 18 to 70
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT06287944 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Duarte, CA on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Duarte
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- City of Hope Comprehensive Cancer Center
- Registry record
- NCT05372614 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Duarte, CA on ClinicalTrials.gov.
Ask about studies near Duarte
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
377 studies recruiting across 44 cities.
Los Angeles
156 studies recruiting.
San Francisco
66 studies recruiting.
La Jolla
37 studies recruiting.
Orange
36 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections